|
Myers, D E; Chandan-Langlie, M; Chelstrom, L M et al. (1996) In vitro and in vivo anti-leukemic efficacy of cyclic AMP modulating agents against human leukemic B-cell precursors. Leuk Lymphoma 22:259-64
|
|
Uckun, F M; Waddick, K G; Mahajan, S et al. (1996) BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273:1096-100
|
|
Messinger, Y; Yanishevski, Y; Avramis, V I et al. (1996) Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside. Clin Cancer Res 2:1533-42
|
|
Uckun, F M; Tuel-Ahlgren, L; Waddick, K G et al. (1996) Physical and functional interactions between Lyn and p34cdc2 kinases in irradiated human B-cell precursors. J Biol Chem 271:6389-97
|
|
Uckun, F M; Reaman, G H (1995) Immunotoxins for treatment of leukemia and lymphoma. Leuk Lymphoma 18:195-201
|
|
Myers, D E; Uckun, F M (1995) An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia. Leuk Lymphoma 18:119-22
|
|
Uckun, F M; Chandan-Langlie, M; Dockham, P A et al. (1994) Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide. Leuk Lymphoma 13:417-28
|
|
Waddick, K G; Chae, H P; Tuel-Ahlgren, L et al. (1993) Engagement of the CD19 receptor on human B-lineage leukemia cells activates LCK tyrosine kinase and facilitates radiation-induced apoptosis. Radiat Res 136:313-9
|
